Infectio Diagnostic, Inc. (IDI) is a biotechnology company which develops diagnostic tests for the detection and identification of bacterial, fungal and parasite infections in human. The development of IDI products is done from patented genomic material and technology belonging to IDI. The company was founded in 1995.

GeneOhm Sciences Canada, Inc. develops diagnostic tests for the detection and identification of bacterial infections, fungal, and parasite infections. The company is headquartered in Sainte-Foy, Canada.

Fraunhofer USA, Inc. is a non-profit, research and development organization, which provides applied research services. It conducts applied R&D to customers from industry and state and federal governments. The firm develops and validates scientific applications and technologies for industrial innovation in the USA. The company was founded in 1994 and is headquartered in Plymouth, MI.

Ambria Dermatology AB, a research and development company, focuses on solutions in dermatology science. It offers technology platform, which includes pentane-1,5-diol delivery platform for the dermal delivery of topically applied pharmaceuticals, cosmeceuticals, and products for technical use. The company is based in Helsingborg, Sweden. As of October 30, 2009, Ambria Dermatology AB operates as a subsidiary of Natumin Pharma AB.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.

Cepheid Inc (NASDAQ: CPHD) is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market. The company's systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. It was the winner of 2006 Industrial Design Excellence Awards for its product, Reagent Bead Dispenser. It won the federal contract by "MRSA Reagent Test Kits" in 2012. One of the company's customers is U.S. Food and Drug Administration (FDA). Danaher acquired Cepheid on November 4, 2016.

Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. The company's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections. Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France.

Tianjin Golden Key Medical Technology Co., Ltd., established on 2018-03-08, Business scope includes general items:Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical equipment rental;Machinery and Equipment Leasing;Office equipment rental service;Health Consulting Services(Does not include medical services);software development;Information Technology Consulting Services;software sales;Retailing of computer software, hardware and auxiliary equipment;Chemical product sales(No licensed chemical products);Machinery sales;Information system integration service;Corporate Image Planning;market survey;Conference and Exhibition Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:medical service;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Golden Key Intelligent Manufacturing (Tianjin) Medical Technology Co., Ltd., established on 2019-12-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Retailing of protective equipment for healthcare workers;Wholesale of protective equipment for medical staff;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Health Consulting Services(Does not include medical services);Medical equipment rental;Machinery and Equipment Leasing;Office equipment rental service;Computer and communication equipment rental;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Computer and Office Equipment Repair;Information system integration service;Information system operation and maintenance services;Information Technology Consulting Services;software development;software sales;Software outsourcing service;Domestic trade agent;Conference and Exhibition Services;market survey(Does not include foreign investigations).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices;Technology Import and Export;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Discuva is a Cambridge (UK)-based Next Generation antibiotic discovery company with an experienced Pharma/Biotech management team and exceptional scientific pedigree. The company was established to address major gaps that exist in the current treatment of infective disease with antibiotics. Using proprietary methods which have come out of recent advances in genomic technologies, Discuva is developing targeted antibiotics against new emerging and drug-resistant pathogens.

Silver Lake Research is a biotech laboratory that develops and produces innovative antibody-based products. Silver Lake Research lowers the limits of antigen detection around the world with simple, inexpensive and accurate innovations of fast tests. They use their powerful Enhanced Affinity Platform to create various monoclonal antibody panels for the detection of targets that are traditionally "difficult" or non-immunogenic.

Beijing Shengquan Gene Medical Laboratory Co., Ltd., established on 2018-01-22, Business scope includes medical examination and medical services,Hemodialysis Medical Services,Pathological Diagnosis Medical Services;Sales of Class III Medical Devices;Medical Testing Technology,Technology development of computer hardware and software,Technical Services,technology transfer,technical consulting;Medical Research and Experimental Development;Sales of medical devicesI,IIkind,Instrumentation,biological reagent(Free of Hazardous Chemicals,Does not contain drugs),Chemical Products(Free of Hazardous Chemicals),Professional setting,plastic products,Electrical Equipment,electronic product.(Market entities independently choose business projects in accordance with the law,Carry out business activities;medical examination medical service,Hemodialysis Medical Services,Pathological Diagnosis Medical Services,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)